The mm Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the mm Hub cannot guarantee the accuracy of translated content. The mm and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The Multiple Myeloma Hub is an independent medical education platform, sponsored by Bristol Myers Squibb, GSK, Johnson & Johnson, Pfizer, Roche and Sanofi. The levels of sponsorship listed are reflective of the amount of funding given. View funders.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out more
Create an account and access these new features:
Bookmark content to read later
Select your specific areas of interest
View mm content recommended for you
Plasma cell dyscrasias
Plasma cell dyscrasias are a heterogeneous group of disorders caused by the monoclonal proliferation of plasma cells in the bone marrow. Multiple myeloma is the most prevalent plasma cell dyscrasia and the second most frequent hematologic malignancy. Other plasma cell dyscrasias include monoclonal gammopathy of undetermined significance, solitary plasmacytoma, AL amyloidosis, POEMS syndrome, and heavy-chain diseases.
Filter by content: